FMO5 and thyroid cancer: In thyroid cancer models, NOX4 expression has been detected in papillary thyroid tumors and was shown to be stimulated by RAS and adenovirus E1A oncogenes, suggesting that NADPH oxidase NOX4 is a mediator of oncogene action (34, 374, 375).